[HTML][HTML] DNA methylation as a diagnostic biomarker for malignant mesothelioma: a systematic review and meta-analysis

J Vandenhoeck, JP van Meerbeeck, E Fransen… - Journal of Thoracic …, 2021 - Elsevier
Malignant mesothelioma is an aggressive cancer type linked to asbestos exposure.
Because of several intrinsic challenges, mesothelioma is often diagnosed in an advanced …

The global burden of pleural diseases

E Vakil, N Taghizadeh… - Seminars in Respiratory …, 2023 - thieme-connect.com
Pleural diseases include a spectrum of disorders broadly categorized into pneumothorax
and pleural effusion. They often cause pain, breathlessness, cough, and reduced quality of …

The epidemiological surveillance of mesothelioma mortality in italy as a tool for the prevention of asbestos exposure

L Fazzo, G Minelli, M De Santis, E Ceccarelli… - International Journal of …, 2023 - mdpi.com
As part of a surveillance plan active since the early 1990s, this study evaluates malignant
mesothelioma (MM) mortality for the time-window 2010–2019 in Italy, a country that banned …

[HTML][HTML] Global, regional, and national trends in mesothelioma burden from 1990 to 2019 and the predictions for the next two decades

W Zhu, J Liu, Y Li, Z Shi, S Wei - SSM-Population Health, 2023 - Elsevier
Objectives We aimed to analyze the secular trends in mesothelioma burden, the effect of
age, period, and birth cohort, and project the global burden over time. Material and methods …

Cause specific mortality in an Italian pool of asbestos workers cohorts

D Ferrante, A Angelini, F Barbiero… - American Journal of …, 2024 - Wiley Online Library
Background Asbestos is a known human carcinogen and is causally associated with
malignant mesothelioma, lung, larynx and ovarian cancers. Methods Cancer risk was …

Advances in immunotherapy of malignant pleural mesothelioma

D Liao, Y Yu, Q Mei, Z Wang, X Li, Y Jia… - OncoTargets and …, 2021 - Taylor & Francis
Malignant pleural mesothelioma (MPM) represents the uncommon cancer originating from
pleural mesothelial cells, which is associated with dismal prognostic outcome. According to …

Mesothelioma due to Workplace Exposure: A Comprehensive Bibliometric Analysis of Current Situation and Future Trends

H Lai, C Hu, M Qu, X Liu, Y Xue, P Xu… - International Journal of …, 2023 - mdpi.com
Background: This article provides an overview of the current status and research progress of
mesothelioma. Methods: A total of 2638 documents published from 1 January 2004 to 30 …

Preclinical models and resources to facilitate basic science research on malignant mesothelioma–a review

BW Johnson, K Takahashi, YY Cheng - Frontiers in Oncology, 2021 - frontiersin.org
Malignant mesothelioma is an aggressive cancer with poor prognosis, predominantly
caused by human occupational exposure to asbestos. The global incidence of …

Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment

O Chimed-Ochir, EM Rath, T Kubo, Y Yumiya… - BMJ Global …, 2022 - gh.bmj.com
Introduction Mesothelioma is a key asbestos-related disease (ARD) but can be difficult to
diagnose. Countries presumably ban asbestos to reduce future ARD burdens, but it is …

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta …

A Zafar, AA Rashid, A Moeed, MJ Tahir, AJ Khan… - BMC cancer, 2024 - Springer
Background Malignant mesothelioma is an aggressive cancer with poor prognosis.
Programmed cell death protein-1 (PD-1) and its ligand 1 (PD-L1) immune checkpoint …